Lv43
750 积分 2025-08-05 加入
Designing Macrocyclic Kinase Inhibitors Using Macrocycle Scaffold Hopping with Reinforced Learning (Macro-Hop)
2小时前
已完结
MacGen: A Web Server for Structure-Based Macrocycle Design
2小时前
已完结
Macrocycles for Conventionally Druggable Targets: Lessons from Macrocyclic Kinase Inhibitors
2小时前
已完结
184MO First-in-human phase I/IIa study of the first-in-class, next-generation CDK4-selective inhibitor PF-07220060 in combination with endocrine therapy (ET) in patients (pts) with HR+/HER2− metastatic breast cancer (mBC) who progressed on prior CDK4/6 inhibitors (CDK4/6i): Safety and efficacy update
2天前
已关闭
Lessons learned in linking PROTACs from discovery to the clinic
5天前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
12天前
已完结
Chronic urticaria and the pathogenic role of mast cells
1个月前
已完结
Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?
1个月前
已完结
c‐KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future Directions
1个月前
已完结
Proteins from Stressed Mesenchymal Stem Cells Can Repair Hair Follicles and Promote Hair Regeneration
1个月前
已完结
皖公网安备34019202002308
